DEX LEVO
LIVE

Serial Number

97184753

Owner

DexLevo Inc.

Attorney

Lenny R. Jiang

Filing Date

Dec 22, 2021

Add to watchlist:

No watchlists yet
View on USPTO

DEX LEVO Trademark

Serial Number: 97184753

DEX LEVO is a trademark filed by DexLevo Inc. on December 22, 2021. The trademark is classified under Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently pending registration.

Owner Contact Info

DexLevo Inc. (3 trademarks)

7F, 704, Yeongdong-daero,

Entity Type: 03

Trademark Details

Filing Date

December 22, 2021

Registration Date

Not Registered

Goods & Services

pharmaceuticals for cosmetic surgery or dermatological use; pharmacological preparations for skin care; pharmacological preparations for facial correction; injectable solutions for improving facial contour, namely, injectable dermal fillers; medicated liquid skin care preparations in ampoules; surgical implants comprised of living tissues; drugs for medical purposes, namely, medicinal preparations for skin disease; injectable dermal tissue fillers for medical purposes; medicinal infusions for treating skin disease; pharmaceuticals for skin disease; medicines for human purposes for skin disease; implants for guided tissue regeneration comprising living tissue; injectable dermal fillers for anti-wrinkle purposes; injectable medicinal solutions, namely, injectable dermal fillers to minimize wrinkles; injectable dermal fillers; implantable medicines, namely, implantable scaffolds comprising living tissue for maintaining tissue contour; injectable pharmaceutical preparations for facial contour improvement for therapeutic purposes; injectable dermal tissue fillers consisting of colloidal solutions for medical purposes; pharmaceuticals consisting of colloidal solutions for medical purposes being used for contouring wrinkles, sores, lips, face and body, skin renewal and filling; skin grafts; pre-filled syringes for medical purposes being syringes sold filled with injectable dermal fillers; functional cosmetics being medicated skin care preparations; drug syringes being syringes sold filled with injectable dermal fillers; skin grafts for medical purposes; medical filler syringes sold filled with injectable dermal fillers; syringes for the skin sold filled with injectable dermal fillers

artificial implants for cosmetic and esthetic surgery; drug syringes being drug delivery devices sold empty; medical instruments for monitoring skin condition; medical apparatus and instruments for monitoring skin condition; syringes for medical purposes; medical skin care apparatus, namely, medical apparatus for measuring skin hydration; medical apparatus for injecting dermal fillers; medical filler syringes sold empty; liquefied implants for contouring wrinkles, sores, lips, face and body, skin renewal and filling; liquid formed artificial implants consisting of colloidal solutions for medical purposes; artificial implants for skin regeneration; syringes for the skin sold empty; medical apparatus and instruments for the treatment of skin, namely, cosmetic apparatus using ultrasound for performing aesthetic skin treatment procedures; implants for guided tissue regeneration comprising non-living materials; implantable medicines, namely, implants comprising non-living materials

functional cosmetics being non-medicated skin care preparations; anti-aging cosmetic preparations; make-up; cosmetic preparations for skin care; anti-wrinkle creams for cosmetic purposes; wrinkle removing skin care preparations; cosmetic preparations consisting of colloidal solutions; cosmetic preparations consisting of colloidal solutions for contouring wrinkles, sores, lips, face and body, skin renewal and filling; cosmetic materials for skin renewal and filling, namely, cosmetic preparations; wrinkle minimizing cosmetic preparations for topical facial use; cosmetic preparations for skin renewal; cosmetic preparations

Filing History

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
May 19, 2026 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Sep 21, 2025 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Mar 20, 2025 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Mar 11, 2025 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Sep 10, 2024 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Mar 11, 2024 RCSC
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Mar 4, 2024 RCCK
ASSIGNED TO EXAMINER
Nov 19, 2023 DOCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sep 4, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Sep 4, 2023 GNSL
SUSPENSION LETTER WRITTEN
Sep 4, 2023 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
May 5, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 5, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 5, 2023 TROA
ASSIGNED TO EXAMINER
Jan 20, 2023 DOCK
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 19, 2022 GNRN
NON-FINAL ACTION E-MAILED
Nov 19, 2022 GNRT
NON-FINAL ACTION WRITTEN
Nov 19, 2022 CNRT
ASSIGNED TO EXAMINER
Sep 26, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 28, 2021 NWOS
NEW APPLICATION ENTERED
Dec 25, 2021 NWAP